Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation
Hee Tae Yu, Pil‐Sung Yang, Tae‐Hoon Kim, et al.
Stroke (2018) Vol. 49, Iss. 10, pp. 2421-2429
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Cardiovascular Research Using the Korean National Health Information Database
Eue‐Keun Choi
Korean Circulation Journal (2020) Vol. 50, Iss. 9, pp. 754-754
Open Access | Times Cited: 205
Atrial fibrillation: comorbidities, lifestyle, and patient factors
Eduard Shantsila, Eue‐Keun Choi, Deirdre A. Lane, et al.
The Lancet Regional Health - Europe (2024) Vol. 37, pp. 100784-100784
Open Access | Times Cited: 28
2018 Korean Guideline of Atrial Fibrillation Management
Boyoung Joung, Jung‐Myung Lee, Ki Hong Lee, et al.
Korean Circulation Journal (2018) Vol. 48, Iss. 12, pp. 1033-1033
Open Access | Times Cited: 130
Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic
Robert D. McBane, Victor D. Torres Roldan, Alexander S. Niven, et al.
Mayo Clinic Proceedings (2020) Vol. 95, Iss. 11, pp. 2467-2486
Open Access | Times Cited: 120
Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation
Yi‐Hsin Chan, Hsin‐Fu Lee, Lai‐Chu See, et al.
CHEST Journal (2019) Vol. 156, Iss. 3, pp. 529-543
Closed Access | Times Cited: 110
Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation
Hee Tae Yu, Pil‐Sung Yang, Eunsun Jang, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 12
Open Access | Times Cited: 72
Pharmacokinetics and pharmacodynamics of direct oral anticoagulants
Ben Hindley, Gregory Y.H. Lip, Asako McCloskey, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 12, pp. 911-923
Open Access | Times Cited: 20
Oral Anticoagulant Agents in Patients With Atrial Fibrillation and CKD: A Systematic Review and Pairwise Network Meta-analysis
Xiaole Su, Bingjuan Yan, Lihua Wang, et al.
American Journal of Kidney Diseases (2021) Vol. 78, Iss. 5, pp. 678-689.e1
Closed Access | Times Cited: 37
Efficacy and Safety of Oral Anticoagulants for Atrial Fibrillation Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Tae‐Min Rhee, So‐Ryoung Lee, Eue‐Keun Choi, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 21
Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta-analysis of real-world evidences
Yoga Waranugraha, Ardian Rizal, Mokhamad Fahmi Rizki Syaban, et al.
The Egyptian Heart Journal (2021) Vol. 73, Iss. 1
Open Access | Times Cited: 25
Effectiveness and Safety of Dose‐Specific DOACs in Patients With Atrial Fibrillation: A Systematic Review and Network Meta‐Analysis
Sang-Hyeon Oh, Seunghyun Cheon, Seo-Yong Choi, et al.
Cardiovascular Therapeutics (2025) Vol. 2025, Iss. 1
Open Access
Renal function and adverse clinical events in anticoagulated patients with atrial fibrillation: insights from the GLORIA-AF Registry Phase III
Yang Liu, Steven Ho Man Lam, Giulio Francesco Romiti, et al.
Journal of Thrombosis and Thrombolysis (2025)
Open Access
A mini review on the regulation of coagulation homeostasis through interfering with vitamin K-dependent coagula-tion/anticoagulation factors
Jian Tong, Yuan Zhao, Yongchao Jin, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151494-151494
Open Access
Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis
Yi‐Hsin Chan, Hsin‐Fu Lee, Tze‐Fan Chao, et al.
Cardiovascular Drugs and Therapy (2019) Vol. 33, Iss. 6, pp. 701-710
Closed Access | Times Cited: 28
The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis
Sarah W.Y. Lok, Wai Han Yiu, Hongyu Li, et al.
Clinical Science (2020) Vol. 134, Iss. 21, pp. 2873-2891
Open Access | Times Cited: 25
The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared to warfarin: Results from a real-world data analysis
Oh Young Bang, Young Keun On, Myung‐Yong Lee, et al.
PLoS ONE (2020) Vol. 15, Iss. 11, pp. e0242922-e0242922
Open Access | Times Cited: 24
Stroke Prevention in Atrial Fibrillation
Chern‐En Chiang, Tze‐Fan Chao, Eue‐Keun Choi, et al.
JACC Asia (2022) Vol. 2, Iss. 5, pp. 519-537
Open Access | Times Cited: 14
Safety of direct oral anticoagulants in real–world clinical practice: translating the trials to everyday clinical management
Ameenathul M. Fawzy, Wangyang Yang, Gregory Y.H. Lip
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 3, pp. 187-209
Closed Access | Times Cited: 21
Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants – A systematic review
Thomas R. Meinel, Sébastien Frey, Marcel Arnold, et al.
PLoS ONE (2019) Vol. 14, Iss. 3, pp. e0213379-e0213379
Open Access | Times Cited: 21
Determinants for under‐ and overdosing of direct oral anticoagulants and physicians' implementation of clinical pharmacists' recommendations
Souad Moudallel, Pieter Cornu, Alain Dupont, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 2, pp. 753-763
Open Access | Times Cited: 17
Efficacy and Safety of Renal Function on Edoxaban Versus Warfarin for Atrial Fibrillation: A Systematic Review and Meta-Analysis
Yapeng Wang, Li Li, Zhanlan Wei, et al.
Medicines (2023) Vol. 10, Iss. 1, pp. 13-13
Open Access | Times Cited: 5
The safety of NOACs in atrial fibrillation patient subgroups: A narrative review
Gregory Y.H. Lip
International Journal of Clinical Practice (2018) Vol. 73, Iss. 2, pp. e13285-e13285
Open Access | Times Cited: 15
The risk of gastrointestinal hemorrhage with non-vitamin K antagonist oral anticoagulants
Hyun Jin Oh, Kum Hei Ryu, Byung‐Joo Park, et al.
Medicine (2021) Vol. 100, Iss. 11, pp. e25216-e25216
Open Access | Times Cited: 12
Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
Wenhao Li, Yanxia Zhou, Siqi Chen, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register
Gualtiero Palareti, Emilia Antonucci, Cristina Legnani, et al.
BMJ Open (2020) Vol. 10, Iss. 11, pp. e040449-e040449
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top